- Home
- FCBC vs BBNX Comparison
FCBC vs BBNX Comparison
Compare FCBC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCBC | BBNX |
|---|---|---|
| Founded | 1874 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.3M | 997.9M |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FCBC | BBNX |
|---|---|---|
| Price | $47.15 | $22.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | 73.2K | ★ 1.2M |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | N/A | ★ 78.95 |
| EPS | ★ 1.82 | N/A |
| Revenue | N/A | ★ $100,251,000.00 |
| Revenue This Year | $12.28 | $34.90 |
| Revenue Next Year | $2.55 | $34.63 |
| P/E Ratio | $25.69 | ★ N/A |
| Revenue Growth | N/A | ★ 53.94 |
| 52 Week Low | $31.21 | $8.80 |
| 52 Week High | $50.17 | $32.71 |
Technical Indicators
Market Signals| Indicator | FCBC | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 64.66 |
| Support Level | $42.49 | $12.45 |
| Resistance Level | $49.84 | $32.42 |
| Average True Range (ATR) | 1.01 | 1.62 |
| MACD | -0.14 | 0.31 |
| Stochastic Oscillator | 44.62 | 86.34 |
Price Performance
Historical ComparisonAbout FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.